How the practical application of these methods can help overcome the complex demands of cancer trials.
Jürgen Hummel
Advertisement
Articles by Jürgen Hummel
Today’s rich oncology pipeline-accounting for nearly 25% of agents in clinical development-promises much needed advances in cancer therapy.
Advertisement
Latest Updated Articles
We Can Improve Oncology Trials Using Adaptive DesignsPublished: January 7th 2015 | Updated:
Improving Oncology Trials Through Adaptive DesignsPublished: April 1st 2015 | Updated:
Advertisement
Advertisement
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
